1-Bromo-3-fluoro-2-nitrobenzene

We are 1-Bromo-3-fluoro-2-nitrobenzene CAS:886762-70-5 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:1-Bromo-3-fluoro-2-nitrobenzene
CAS.NO:886762-70-5
Synonyms:1-Bromo-3-fluoro-2-nitrobenzene
2-Bromo-6-fluoronitrobenzene
2-fluoro-6-bromonitrobenzene
 
Physical and Chemical Properties:
Density 1.8±0.1 g/cm3
Boiling Point 232.0±20.0 °C at 760 mmHg
Melting Point 36-37ºC
Molecular Formula C6H3BrFNO2
Molecular Weight 219.996
Flash Point 94.1±21.8 °C
Vapour Pressure 0.1±0.4 mmHg at 25°C
Index of Refraction 1.580
 
Specification:
Appearance:Off-white to light yellow solid
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Organic synthesis.

1-Bromo-3-fluoro-2-nitrobenzene


Related News: Under the high pressure of environmental protection, if Chinese API companies want to achieve sustainable operation, they must recognize the current situation, increase environmental investment, and carry out industrial upgrades, focusing on new product development, process improvement, CMO business and new technology research. And other businesses to carry out work to improve safety, environmental protection, quality, cost and other capabilities, so as to seize structural opportunities.N,O-Bis(trimethylsilyl)acetamide CAS:10416-59-8 The travel restrictions will take effect on Tuesday, Prime Minister Chung Sye-kyun said, as the number of people testing positive for the coronavirus in South Korea increased to 15.2-Bromopropane It is delivered to hospitals and pharmacies until it reaches the patient.O-(2-MethoxyEthoxy)BenzeneSulfonamide CAS:93093-02-9 Taking Teva as an example, it has 2 large R & D centers and 3 professional R & D centers in 5 countries, which effectively supports the development of Teva’s generic pharmaceutical sector.A Phase 1/2 trial of the combination therapy has been fully enrolled, and the preliminary efficacy and safety data was presented at The American Society of Hematology (ASH) Annual Meeting in December 2018.

Related Products
Product Name
N-Carbobenzyloxy-L-valine View Details
Dolutegravir Sodium View Details
4-Bromo-2-methylpyridine View Details
4-Chloro-3-(trifluoromethyl)phenyl isocyanate manufacturer N,O-Di(2-hydroxyethyl)-2-amino-5-nitrophenol manufacturer N,N-Dimethyldecanamide manufacturer (R,R)-2-amino-1-(4-nitrophenyl)propane-1,3-diol manufacturer 5-bromo-2-fluoro-3-methylpyridine manufacturer